INS and obesity disorder: In obesity and T2DM, the local accumulation of bioactive metabolites—including diacylglycerols, ceramides, and branched-chain amino acid (BCAA) catabolites—within skeletal muscle, adipose tissue, bone, and fascia contributes directly to tissue-specific insulin resistance and metabolic dysfunction.